Stock-based compensation decreased 37.6%
Stock-based compensation changed -37.6% from the comparable as-filed period.
$250,000→$156,0003 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →DAIO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue decreased 13.4%
Revenue changed -13.4% from the comparable as-filed period.
$5.9M→$5.1M3 prior comparisons
Inventory / revenue moved 1979 bp higher
Inventory / revenue changed +1979 basis points from the comparable as-filed period.
100.40%→120.20%3 prior comparisons
Operating margin moved 13 bp higher
Operating margin changed +13 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-14.19%→-14.06%3 prior comparisons
Operating cash-flow margin moved 5133 bp lower
Operating cash-flow margin changed -5133 basis points from the comparable as-filed period.
-5.75%→-57.08%3 prior comparisons
Free-cash-flow margin moved 5073 bp lower
Free-cash-flow margin changed -5073 basis points from the comparable as-filed period.
-10.64%→-61.37%3 prior comparisons
Current assets increased 7.6%
Current assets changed +7.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$20.6M→$22.2M4 prior comparisons
Research & development decreased 17.0%
Research & development changed -17.0% from the comparable as-filed period.
$1.7M→$1.4M3 prior comparisons
Capital expenditure decreased 24.1%
Capital expenditure changed -24.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$291,000→$221,0004 prior comparisons
Trade receivables increased 10.2%
Trade receivables changed +10.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$3.9M→$4.3M4 prior comparisons
Total assets increased 2.2%
Total assets changed +2.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$24.1M→$24.6M4 prior comparisons
R&D / revenue moved 114 bp lower
R&D / revenue changed -114 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
27.94%→26.80%3 prior comparisons
SBC / revenue moved 117 bp lower
SBC / revenue changed -117 basis points from the comparable as-filed period.
4.20%→3.03%3 prior comparisons
Capex / revenue moved 60 bp lower
Capex / revenue changed -60 basis points from the comparable as-filed period.
4.89%→4.29%3 prior comparisons
Selling, general & administrative increased 6.4%
Selling, general & administrative changed +6.4% from the comparable as-filed period.
$2.1M→$2.3M3 prior comparisons
Inventory increased 3.6%
Inventory changed +3.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$6.0M→$6.2M4 prior comparisons
Gross profit decreased 0.8%
Gross profit changed -0.8% from the comparable as-filed period.
$3.0M→$2.9M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.